Medicare decides against tighter management of HIV drugs

Medicare decides against tighter management of HIV drugs

Source: 
Biopharma Dive
snippet: 

The Department of Health and Human Services will continue barring Medicare Part D plans from applying the drug utilization management tools prior authorization and step therapy for beneficiaries taking HIV antiretroviral drugs. A rule proposed in November 2018 would have permitted such practices.